Back

A Drug-Free Pathogen Capture and Neutralizing Nasal Spray to Prevent Emerging Respiratory Infections

Joseph, J.; Baby, H. M.; Quintero, J. R.; Kenney, D.; Mebratu, Y.; Bhatia, E.; Shah, P.; Swain, K.; Kaur, S.; Li, X. L.; Mwangi, J.; Snapper, O.; Nair, R.; Agus, E.; Ranganathan, S.; Kage, J.; Gao, J.; Luo, J. N.; Yu, A.; Douam, F.; Tesfaigzi, Y.; Karp, J.; Joshi, N.

2023-10-03 bioengineering
10.1101/2023.10.02.560602 bioRxiv
Show abstract

Respiratory infections pose a global health crisis. Vaccines are pathogen specific, and new vaccines are needed for mutants and emerging pathogens. Here, we report a "drug free" prophylactic platform - a "Pathogen Capture and Neutralizing Spray" (PCANS) that acts via a multi-pronged approach to prevent a broad spectrum of respiratory infections. PCANS forms a protective coating in the nasal cavity that enhances the capture of large respiratory droplets. The coating acts as a physical barrier against a broad spectrum of viruses and bacteria, and rapidly neutralizes them, reducing the pathogen load by >99.99%. In mice, PCANS showed nasal retention for at least 8 h and was safe for daily administration. A single prophylactic dose of PCANS protected mice against supra-lethal dosages of a mouse-adapted H1N1 Influenza virus (PR8), reduced lung viral titer by >99.99%, improved survival, and suppressed pathological manifestations. Together, our data suggest PCANS as a promising daily-use prophylactic approach against current and emerging respiratory infections.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.